Skip to main content
An official website of the United States government

Imaging Tracer Agent (PSMA-Targeting C’ Dots) for the Detection of Prostate Cancer

Trial Status: active

This phase I trial studies how well an imaging tracer agent (PSMA-targeting C’ dots) works for the detection of prostate cancer. PSMA-targeting C’ dots is an imaging tracer agent targeted to the protein PSMA (prostate-specific membrane antigen), which is located only on prostate cancer cells. PET/MRI scans done after an injection of PSMA-targeting C’ dots may detect PSMA proteins more precisely than other imaging test. PSMA-targeting C’ dots tracer may help surgeons locate prostate cancer cells more accurately before and during surgery and improve diagnosis and treatment of prostate cancer.